CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...

1 Semaglutide is the generic name of the popular type 2 diabetes and weight loss medications Ozempic, Wegovy, and Rybelsus. The other medications included in the negotiations are varied ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

The FTC’s findings—which analyzed 51 specialty generic drugs from 2017 to 2022—showed these pharmacy benefit managers’ (PBMs') affiliated pharmacies spun up $7.3 billion in excess revenue ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...